Search research articles
Contact Us
Filters
Showing results (71-80 of 322) with videos related to
Page
of 33
Sort By:
Clinical and Experimental Immunology
|
December 1, 1983
Characterization of polyclonal autoantibodies specific for beta 2-microglobulin in multiple myeloma sera
C Vincent, J P Revillard, R Bataille
British Journal of Haematology
|
June 1, 1997
CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2
A Bergamo, R Bataille, C Pellat-Deceunynck
British Journal of Haematology
|
November 1, 1983
Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging
R Bataille, B G Durie, J Grenier
Clinical and Experimental Immunology
|
March 1, 1986
Production of interleukin 2 in multiple myeloma
T Commes, B Klein, M Jourdan, et al.
Hematology/Oncology Clinics of North America
|
April 1, 1997
Pathogenesis and management of bone lesions in multiple myeloma
R Bataille, S C Manolagas, J R Berenson
British Journal of Haematology
|
January 1, 1983
Multiple myeloma: optimal use of salmon calcitonin in the management of myeloma osteoclastic bone disease
R Bataille, M Tenoudji-Cohen, J F Rossi
La Nouvelle Presse Medicale
|
March 1, 1980
[Late interhepatodiaphragmatic metastases of uterine cancers]
M Bressollette, R Bataille, Y Getin, et al.
Annales De Medecine Interne
|
January 1, 1996
[Role of glucocorticoids in the treatment of multiple myeloma]
N Juge-Morineau, J L Harousseau, R Bataille
Radiology
|
December 1, 1982
Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients
R Bataille, J Chevalier, M Rossi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 1, 2014
[Dr. Stéphane Leduc and the first treatments of cancer by irradiation in Nantes and France]
E Drouin, F-R Bataille, M-A Mahé
Page
of 33
Search research articles
Search
Showing results (71-80 of 322) with videos related to
Sort By:
Page
of 33
Clinical and Experimental Immunology
|
December 1, 1983
Characterization of polyclonal autoantibodies specific for beta 2-microglobulin in multiple myeloma sera
C Vincent, J P Revillard, R Bataille
British Journal of Haematology
|
June 1, 1997
CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2
A Bergamo, R Bataille, C Pellat-Deceunynck
British Journal of Haematology
|
November 1, 1983
Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging
R Bataille, B G Durie, J Grenier
Clinical and Experimental Immunology
|
March 1, 1986
Production of interleukin 2 in multiple myeloma
T Commes, B Klein, M Jourdan, et al.
Hematology/Oncology Clinics of North America
|
April 1, 1997
Pathogenesis and management of bone lesions in multiple myeloma
R Bataille, S C Manolagas, J R Berenson
British Journal of Haematology
|
January 1, 1983
Multiple myeloma: optimal use of salmon calcitonin in the management of myeloma osteoclastic bone disease
R Bataille, M Tenoudji-Cohen, J F Rossi
La Nouvelle Presse Medicale
|
March 1, 1980
[Late interhepatodiaphragmatic metastases of uterine cancers]
M Bressollette, R Bataille, Y Getin, et al.
Annales De Medecine Interne
|
January 1, 1996
[Role of glucocorticoids in the treatment of multiple myeloma]
N Juge-Morineau, J L Harousseau, R Bataille
Radiology
|
December 1, 1982
Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients
R Bataille, J Chevalier, M Rossi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 1, 2014
[Dr. Stéphane Leduc and the first treatments of cancer by irradiation in Nantes and France]
E Drouin, F-R Bataille, M-A Mahé
Page
of 33